Sign in
4

Changes in Ownership

Allogene Therapeutics, Inc. Filed Acc 0001214659-20-002736

Chief Technical Officer sold 3,750 shares at $19.19 ($71,980)

From the SEC's structured data for this filing

Trades in this filing

MOORE ALISON · Chief Technical Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2020-03-16 Sale : show line 1 in the form −3,750 $19.19 $71,980 63,021 D
Open-market sales · 3,750 sh · avg $19.19 · $71,980
Loading xslF345X03/marketforms-48347.xml…